Financhill
Sell
46

AVIR Quote, Financials, Valuation and Earnings

Last price:
$3.66
Seasonality move :
-23.12%
Day range:
$3.54 - $3.67
52-week range:
$2.46 - $4.02
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.84x
P/B ratio:
0.90x
Volume:
375.3K
Avg. volume:
399.5K
1-year change:
10.94%
Market cap:
$285.2M
Revenue:
--
EPS (TTM):
-$1.78

Earnings Data

Next earnings date for AVIR
Mar 05
2026
Most recent earnings per share
-$0.53
Missed by $0.12
(Nov 12/2025)
Consensus Estimate
-$0.42
(Nov 12/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

AVIR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/05/2026 Q4 -- -- -- -$0.49 --
11/12/2025 Q3 -- -- -$0.53 -$0.42 -$0.12
08/07/2025 Q2 -- -- -$0.44 -$0.42 -$0.03
05/15/2025 Q1 -- -- -$0.40 -$0.41 $0.01
03/06/2025 Q4 -- -- -$0.40 -$0.29 -$0.11
11/07/2024 Q3 -- -- -$0.37 -$0.43 $0.06
08/07/2024 Q2 -- -- -$0.48 -$0.77 $0.29
05/14/2024 Q1 -- -- -$0.75 -$0.61 -$0.14
02/28/2024 Q4 -- -- -$0.47 -$0.50 $0.03
11/08/2023 Q3 -- -- -$0.40 -$0.46 $0.06
08/08/2023 Q2 -- -- -$0.34 -$0.47 $0.13
05/08/2023 Q1 -- -- -$0.43 -$0.48 $0.05
02/28/2023 Q4 -- -- -$0.41 -$0.45 $0.04
11/07/2022 Q3 -- -- -$0.10 -$0.44 $0.34
08/08/2022 Q2 -- -- -$0.38 -$0.49 $0.11
05/10/2022 Q1 -- -- -$0.51 -$0.56 $0.05
02/28/2022 Q4 -- -- $1.34 $0.52 $0.82
11/11/2021 Q3 -- -- -$0.34 -$0.05 -$0.29
08/12/2021 Q2 -- -- $0.02 $0.00 $0.02
05/13/2021 Q1 -- -- $0.34 -$0.05 $0.39
03/30/2021 Q4 -- -- $0.25 $0.25 $0.00
12/10/2020 Q3 -- -- -$0.22 -$1.81 $1.59
06/30/2020 Q2 -- -- -$0.21 -- --
03/31/2020 Q1 -- -- -$0.08 -- --
12/31/2019 Q4 -- -- -$0.10 -- --
09/30/2019 Q3 -- -- -$0.08 -- --

Atea Pharmaceuticals, Inc. Earnings Questions

  • How Much did Atea Pharmaceuticals, Inc. Generate in Revenue Last Quarter?

    Atea Pharmaceuticals, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Atea Pharmaceuticals, Inc. Beat Earnings Last Quarter?

    Atea Pharmaceuticals, Inc. announced earnings per share of -$0.53 which represents a miss of analyst forecast a -$0.42 per share.

  • Is Atea Pharmaceuticals, Inc. Profitable?

    Atea Pharmaceuticals, Inc. reported -$104K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Atea Pharmaceuticals, Inc. EPS Next Year?

    Atea Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$2.00 per share to -$1.73 per share next year representing a decrease of -13.68%.

  • When is Atea Pharmaceuticals, Inc.'s Earnings Date?

    Atea Pharmaceuticals, Inc.'s next earnings date is March 5, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
72
GLTO alert for Dec 27

Galecto, Inc. [GLTO] is up 16.92% over the past day.

Sell
20
SMX alert for Dec 27

SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.

Sell
11
CDNAF alert for Dec 27

Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock